Can a blood pressure drug lift depression? new trial aims to find out
NCT ID NCT06408246
First seen Jan 11, 2026 · Last updated Apr 30, 2026 · Updated 17 times
Summary
This study tests whether guanfacine, a medication typically used for blood pressure, can improve brain function and reduce depressive symptoms. Researchers will enroll 162 adults with depression to see if the drug helps with thinking problems and leads to remission. The goal is to understand how guanfacine affects brain networks and whether it can ease depression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford Psychiatry and Behavioral Sciences Department
RECRUITINGPalo Alto, California, 94305, United States
-
University of Illinois at Chicago
RECRUITINGChicago, Illinois, 60607, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.